Compare Iovance Biotherapeutics Inc. Common Stock (IOVA) vs Open Text Corporation (OTEX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Iovance Biotherapeutics Inc. Common Stock vs Open Text Corporation — how do they compare? Iovance Biotherapeutics Inc. Common Stock trades at $14.6 (market cap $6.04B), while Open Text Corporation trades at $23.7 (market cap $5.61B). The key difference: Iovance Biotherapeutics Inc. Common Stock and Open Text Corporation are close in size by market cap, and Open Text Corporation pays a 4.82% dividend while Iovance Biotherapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Iovance Biotherapeutics Inc. Common Stock for 0 Days and Open Text Corporation for 23 Days on average.
| IOVA | OTEX | |
|---|---|---|
Market Cap | $6.04B | $5.61B |
Volume | 14,805,993 | 1,197,475 |
Sector | Health | Technology |
52-Week High | $14.82 | $39.69 |
52-Week Low | $1.81 | $20.01 |
Typical Hold Time | 0 Days | 23 Days |
Enterprise Value | $5.97B | $10.63B |
Dividend Yield | — | 4.82% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
OpenText (OTEX) trades at $23.595, up 1.97% today, showing strong earnings momentum with three consecutive quarterly beats. The stock trades at discounted valuations (P/E 9.01, P/S 1.1) compared to sector peers. Recent corporate actions include a $1 billion senior secured notes offering and strategic AI partnership with Cohere, while technical indicators signal near-term bearish pressure with RSI at overbought levels.
The investment case balances attractive fundamentals against technical headwinds. Strong cloud growth (22.5% bookings growth in fiscal 2026) and improving margins support upside to the $28.30 consensus target, but high debt levels and bearish technical signals warrant caution. The stock offers value opportunity for patient investors despite near-term volatility.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Iovance Biotherapeutics Inc. Common Stock
Iovance Biotherapeutics develops cell therapies for cancer. Its approach uses tumor-infiltrating lymphocytes, or TIL, to target solid tumors.
Read more on IOVA →About Open Text Corporation
Open Text Corporation is a global leader in Enterprise Information Management (EIM) software and solutions. The company provides a comprehensive platform that helps organizations manage, secure, and leverage their unstructured digital content, including documents, emails, and media files. OTEX's offerings span content management, business process management, customer experience management, and security, serving large enterprises across various industries worldwide.
Read more on OTEX →
